Literature DB >> 31293842

Reversible Ocular Toxicity of Oxaliplatin: A Case Report.

Arish Noor1, Aakash Desai2, Meghana Singh3.   

Abstract

Oxaliplatin, a platinum-based chemotherapy agent, is commonly used in the treatment of various malignancies. Common adverse effects involve neurological, hematological, gastrointestinal system, and hypersensitivity, and rarely ocular changes have also been reported. We describe the case of a 71-year-old male, who developed reversible ocular toxicity after receiving oxaliplatin for treatment for pancreatic cancer.

Entities:  

Keywords:  ocular toxicity; oxaliplatin

Year:  2019        PMID： 31293842      PMCID： PMC6605969          DOI： 10.7759/cureus.4582

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  4 in total

1.  Transient Vision Loss - A Rare Oxaliplatin-Induced Ophthalmologic Side Effect: A Report of Two Cases.

Authors:  Loic Ah-Thiane; Jean-Luc Raoul; Sandrine Hiret; Hélène Senellart; Frédéric Dumont; Judith Raimbourg
Journal:  Case Rep Oncol       Date:  2021-03-18

2.  Amaurosis Fugax: A Rare Oxaliplatin-Induced Ocular Toxicity - A Report of Three Cases.

Authors:  Mutahar Ali Tunio; Karen Phillips; Peter Baker
Journal:  Case Rep Oncol       Date:  2022-02-14

Review 3.  Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review.

Authors:  Minas Sakellakis; Nikolaos Spathas; Konstantinos T Tsaousis; Emmanouil N Nikitiadis; Helena Linardou; Vasilios F Diakonis
Journal:  Cureus       Date:  2022-07-26

4.  Oxaliplatin-Associated Amaurosis Fugax.

Authors:  Kimitoshi Kubo; Noriko Kimura; Ryosuke Watanabe; Masayuki Higashino; Momoko Tsuda; Mototsugu Kato
Journal:  Case Rep Oncol       Date:  2021-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.